Standardized Definition for Structural Valve Degeneration Summary

The VIVID (Valve-in-Valve International Data) group have published a standardised set of definitions for structural valve degeneration (SVD) of surgical and transcatheter aortic valve bioprostheses. They also make recommendations for the timing of clinical and imaging follow-up.

Dvir D, Bourguignon T, Otto CM, Hahn RT, Rosenhek R, Webb JG, et al. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves. Circulation. 2018 Jan 23;137(4):388–99.



  • An acquired intrinsic bioprosthetic valve abnormality defined as deterioration of the leaflets or supporting structures
  • Resulting in thickening, calcification, tearing, or disruption of the prosthetic valve materials with eventual associated valve hemodynamic dysfunction
  • Is caused by tissue disruption or thickening over time because of mechanical stress + abnormal flow shear stress
  • SVD does NOT include patient-prosthesis mismatch, device malposition, paravalvular regurgitation, & abnormal frame expansion
  • The process is usually gradual (over years) and so has been divided into stage

 Echocardiographic Assessment


Clinical Application

  • Routine post-procedural anticoagulation is currently a IIa recommendation for 3 months post SAVR
  • If a change in mean gradient > 10 mmHg or a clinical event (stroke, heart failure, decreased EF, new PVL) then 4D CT or TOE should be done
    • If leaflets are thickened should consider a trial of anticoagulation
  • All patients diagnosed with SVD should undergo a repeat TTE within 3 to 6 months to evaluate for rapid progression
  • For symptomatic patients with severe AR or AS, or moderate mixed AS/AR, should be considered for redo SAVR or valve-in-valve TAVR


About The Author

Michael Seco

Dr Michael Seco is a Cardiothoracic Surgery Registrar at Royal Prince Alfred Hospital, Sydney, Australia. He has research interests in minimally invasive adult cardiac surgical techniques, including robotic-assisted coronary artery bypass grafting, transcatheter aortic valve implantation, and off-pump surgery. Dr Seco also builds and develops large scale databases used to perform clinical studies.

SHDA is supported by

Recent Tweets


Upcoming Meetings


21janAll Day25American Society of Echocardiography (ASE) Echo Hawaii

27janAll Day29Society of Thoracic Surgeons (STS) 55th Annual MeetingSTS 2018


15febAll Day17PCR Tokyo Valves